TABLE 5.

Unadjusted and adjusted prognostic value of ln (uPCR) for secondary adverse outcomes^*

Secondary outcomes	Unadjusted OR (95% CI)	p	Adjusted OR (95% CI)	p
Severe hypertension	2.111 (1.853–2.405)	.000	1.989(1.726–2.293)	.000
Postpartum hemorrhage	0.905 (0.769–1.064)	.227	0.832 (0.687–1.009)	.062
Chorioamnionitis	1.333 (1.126–1.579)	.001	1.166 (0.966–1.406)	.109
Oligohydramnios	1.188 (0.391–1.517)	.166	1.015 (0.776–1.329)	.911
Thrombocytopenia	1.315 (1.040–1.663)	.022	1.255 (0.967–1.628)	.087
Hypoalbuminemia	3.834 (2.878–5.107)	.000	3.801 (2.757–5.240)	.000
Fetal distress	0.967 (0.805–1.163)	.722	0.929 (0.759–1.138)	.477
Preterm birth	2.769 (2.378–3.224)	.000	2.279 (1.906–2.724)	.000

^*Only women with preeclampsia were included; Data are adjusted for maternal age, BMI before pregnancy, parity, mode of conception and gestational age at diagnosis of preeclampsia in multiple logistic regressions.